2′,2′-Difluorodeoxyuridine
2’,2’-Difluorodeoxyuridine (dFdU) is the main metabolite of Gemcitabine. 2’,2’-Difluorodeoxyuridine causes a concentration- and schedule- dependent radiosensitising effect in vitro. 2’,2’-Difluorodeoxyuridine arrests cell cycle at the early S phase and induces apoptosis in cancer cells[1][2][3].
Product Specifications
CAS Number
114248-23-6
Product Name Alternative
DFdU; 2',2'-Difluoro-2'-deoxyuridine
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Apoptosis; Drug Metabolite
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/2-2-difluorodeoxyuridine.html
Purity
99.87
Solubility
DMSO : 125 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(N1)N([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C=CC1=O
Molecular Formula
C9H10F2N2O5
Molecular Weight
264.18
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human FZD8 shRNA (UAS) - Lentiviral human FZD8 shRNA (UAS, GFP) plasmid
